Vaccine maker Bharat Biotech on Wednesday mentioned the Central Drugs Standard Control Organisation (CDSCO) has authorized the extension of shelf lifetime of its Covid-19 vaccine Covaxin as much as 12 months from the date of manufacture.
“The CDSCO has approved the extension of shelf life of Covaxin up to 12 months, from the date of manufacture. This approval of shelf life extension is based on the availability of additional stability data, which was submitted to CDSCO,” Bharat Biotech mentioned in a tweet.
— BharatBiotech (@BharatBiotech) November 3, 2021
The shelf life extension has been communicated to “our stakeholders,” it added.